Dynavax Gets Word from FDA on HEPLISAV Hepatitis B Vaccine - Trading Markets (press release) PDF Print

... the clinical hold on the two HEPLISAV Investigational New Drug (IND) Applications, for healthy adults and patients with end-stage renal disease (ESRD). ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.